VERA FY 2025 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$468,000

Operating Income

-$315M

Net Income

-$300M

EPS (Diluted)

$-4.66

Cash Flow

Operating Cash Flow

-$241M

Free Cash Flow

-$242M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$735M

Total Liabilities

$130M

Stockholders' Equity

$605M

Cash & Equivalents

$355M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$468,000	$0	—
Operating Income	-$315M	-$167M	-88.7%
Net Income	-$300M	-$152M	-96.9%